胰腺腺癌中ZP3表达:它对预后和治疗的影响

Guizhen Lyu1, Dongbing Li2

  • 1Scientific Research Center, Dongguan Labway Medical Testing Laboratory Co., Ltd., Dongguan, 523429, China.

PubMed
概括

在胰腺管道腺癌 (PAAD) 中,Zona pellucida glycoprotein 3 (ZP3) 异常表达. 较高的ZP3水平与较低的存活率和影响治疗疗效相关,这表明它作为预后生物标志物的潜力.